Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Practice Tip: The FDA's Good Reprint Practices and Product Liability
The Food and Drug Administration (FDA) recently finalized its guidance document entitled “Good Reprint Practices for the Distribution of Medical Journal Articles and Medical Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices” (the “GRP Guidance”), which describes the conditions under which the agency will allow drug and device companies to disseminate certain off-label use information proactively. Because dissemination of off-label information has the potential to affect product liability exposure, it is worth examining the content of the GRP Guidance carefully. To illustrate the point, I note that the GRP Guidance and the recent sermon of my rabbi share similar characteristics. Both focus on the potential of good news, but also offer a note about caution in saying too much.
My rabbi related a joke he heard: A man is pulled over by a state police officer. The officer informs the driver, “Your license number was drawn in a special lottery, and you won $1 million.” The driver responds, “Even though I don't have my license?” and his wife, in the passenger seat, offers, “Officer, don't listen to a word he says, he's drunk.” The man in the back seat chimes in, “How did he know this is not your car?” I will not attempt to convey my rabbi's moral message from this tale but, for some reason, it made me think of the FDA's GRP Guidance. My mind works in mysterious ways. While the guidance offers pharmaceutical and medical device manufacturers guidance about disseminating specific kinds of off-label information according to proscribed conditions, companies must be careful and cautious in recognizing the potential trapdoor of product liability exposure if they say too much.
This premium content is locked for Entertainment Law & Finance subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
New York's Latest Cybersecurity Commitment
On Aug. 9, 2023, Gov. Kathy Hochul introduced New York's inaugural comprehensive cybersecurity strategy. In sum, the plan aims to update government networks, bolster county-level digital defenses, and regulate critical infrastructure.
Law Firms are Reducing Redundant Real Estate by Bringing Support Services Back to the Office
A trend analysis of the benefits and challenges of bringing back administrative, word processing and billing services to law offices.
Bit Parts
Summary Judgment Denied Defendant in Declaratory Action by Producer of To Kill a Mockingbird Broadway Play Seeking Amateur Theatrical Rights
Risks of “Baseball Arbitration” in Resolving Real Estate Disputes
“Baseball arbitration” refers to the process used in Major League Baseball in which if an eligible player's representative and the club ownership cannot reach a compensation agreement through negotiation, each party enters a final submission and during a formal hearing each side — player and management — presents its case and then the designated panel of arbitrators chooses one of the salary bids with no other result being allowed. This method has become increasingly popular even beyond the sport of baseball.
One Overlooked Element of Executive Safety: Data Privacy
Executives have access to some of the company's most sensitive information, and they're increasingly being targeted by hackers looking to steal company secrets or to perpetrate cybercrimes.